Bluebird Wins FDA Approval of Gene Therapy For Rare Brain Disorder

The Food and Drug Administration on Friday granted accelerated approval to a personalized gene therapy for an ultra-rare childhood brain disease, called cerebral adrenoleukodystrophy or CALD.